Skip to content

MED INSPIRE: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MED INSPIRE

BE 0657.885.672
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€41,387
2024 · -€49,829+€8,442
Equity
€10,864
2024 · €52,251-€41,387
Cash
€2,547
2024 · €37,475-€34,928
Balance sheet total
€18,200
2024 · €60,238-€42,037

Largest movements

2024 to 2025
Assets
  • Cash -€34,928

    down €34,928 (-93.2%), from €37,475 to €2,547

    mainly Net result for the year (-€41,387) and Tax, wage and social debts (-€1,628)

  • Deferred charges and accrued income -€4,152

    down €4,152 (-94.1%), from €4,411 to €259

  • Tangible fixed assets -€3,346

    down €3,346 (-18.5%), from €18,121 to €14,775

    of which Other tangible fixed assets: -€2,705

Equity and liabilities
  • Profit (loss) carried forward -€41,387

    down €41,387 (-40.7%), from -€101,749 to -€143,136

  • Tax, wage and social debts -€1,628

    no longer reported in 2025 (was €1,628)

  • Trade debts +€871

    up €871 (+77.6%), from €1,123 to €1,994

Income statement
  • Gross operating margin +€5,892

    up €5,892 (+14.1%), from -€41,872 to -€35,979

  • Financial charges -€3,446

    down €3,446 (-73.0%), from €4,720 to €1,274

    of which Non-recurring financial charges: -€3,862

  • Other operating charges +€787

    new in 2025: €787

  • Depreciation +€486

    up €486 (+17.0%), from €2,860 to €3,346

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€49,829
Gross operating margin +€5,892
Depreciation -€486
Other operating charges -€787
Financial charges +€3,446
Taxes +€377
Result 2025 -€41,387
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€35,018
Investment +€90
Financing €0
Cash 2024 €37,475
Net result for the year -€41,387
Depreciation +€3,346
Receivables within one year -€479
Deferred charges and accrued income +€4,152
Trade debts +€871
Tax, wage and social debts -€1,628
Other debts +€347
Accrued charges and deferred income -€242
Investment in fixed assets (net) +€90
Cash 2025 €2,547
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €60,238 €18,200 -€42,037 -69.8%
Fixed assets 21/28 €18,351 €14,915 -€3,436 -18.7%
Tangible fixed assets 22/27 €18,121 €14,775 -€3,346 -18.5%
Furniture and vehicles 24 €1,690 €1,048 -€642 -38.0%
Other tangible fixed assets 26 €16,431 €13,727 -€2,705 -16.5%
Financial fixed assets 28 €230 €140 -€90 -39.1%
Current assets 29/58 €41,886 €3,285 -€38,601 -92.2%
Amounts receivable within one year 40/41 - €479 +€479
Other amounts receivable 41 - €479 +€479
Cash at bank and in hand 54/58 €37,475 €2,547 -€34,928 -93.2%
Deferred charges and accrued income 490/1 €4,411 €259 -€4,152 -94.1%
Total equity and liabilities 10/49 €60,238 €18,200 -€42,037 -69.8%
Equity 10/15 €52,251 €10,864 -€41,387 -79.2%
Contributions 10/11 €150,000 €150,000 = 0.0%
Capital 10 €150,000 €150,000 = 0.0%
Issued capital 100 €150,000 €150,000 = 0.0%
Reserves 13 €4,000 €4,000 = 0.0%
Non-distributable reserves 130/1 €4,000 €4,000 = 0.0%
Legal reserve 130 €4,000 €4,000 = 0.0%
Profit (loss) carried forward 14 -€101,749 -€143,136 -€41,387 -40.7%
Amounts payable 17/49 €7,987 €7,336 -€651 -8.2%
Amounts payable within one year 42/48 €7,745 €7,335 -€409 -5.3%
Trade debts 44 €1,123 €1,994 +€871 +77.6%
Suppliers 440/4 €1,123 €1,994 +€871 +77.6%
Taxes, remuneration and social security 45 €1,628 - -€1,628
Taxes 450/3 €1,628 - -€1,628
Other amounts payable 47/48 €4,994 €5,341 +€347 +7.0%
Accrued charges and deferred income 492/3 €242 €0 -€242 -99.9%
Non-recurring operating income 76A €3,252 - -€3,252
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,860 €3,346 +€486 +17.0%
Other operating charges 640/8 - €787 +€787
Gross operating margin 9900 -€41,872 -€35,979 +€5,892 +14.1%
Operating profit (loss) 9901 -€44,732 -€40,113 +€4,620 +10.3%
Financial charges 65/66B €4,720 €1,274 -€3,446 -73.0%
Recurring financial charges 65 €858 €1,274 +€416 +48.5%
Non-recurring financial charges 66B €3,862 - -€3,862
Profit (loss) for the period before taxes 9903 -€49,452 -€41,387 +€8,066 +16.3%
Income taxes 67/77 €377 - -€377
Profit (loss) for the period 9904 -€49,829 -€41,387 +€8,442 +16.9%
Profit (loss) for the period to be appropriated 9905 -€49,829 -€41,387 +€8,442 +16.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.